Kamada Ltd. (KMDA) stock analysis

In our weekly check, Kamada Ltd. is graded B (A to F). Of 24 checks on debt, profit, cash flow and trend: 18 pass, warnings: 5, red flags: 1.

Sector: Healthcare · Drug Manufacturers—Specialty & Generic

Strengths

• Low debt
• Easily covers interest
• Margins rising
• Profits backed by cash
• Strong free cash flow

Warning signs

• Small company
• Share dilution
• Thinly traded
• Low return on capital

Next earnings report: 2026-11-09

Similar companies

TKNO · EOLS · TLRY · AQST · IRWD · COLL

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-10

Open the full analysis